Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/136531
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | The Introduction of cPRA and Its Impact on Access to Deceased Donor Kidney Transplantation for Highly Sensitized Patients in Australia |
Author: | Sypek, M.P. Kausman, J.Y. Watson, N. Wyburn, K. Holt, S.G. Hughes, P. Clayton, P.A. |
Citation: | Transplantation, 2021; 105(6):1317-1325 |
Publisher: | Lippincott, Williams & Wilkins |
Issue Date: | 2021 |
ISSN: | 0041-1337 1534-6080 |
Statement of Responsibility: | Matthew P. Sypek, Joshua Y. Kausman, Narelle Watson, Kate Wyburn, Stephen G. Holt, Peter Hughes, and Philip A. Clayton |
Abstract: | BACKGROUND: In March 2016, Australia's deceased donor kidney allocation program introduced calculated panel reactive antibody (cPRA) based on antibody exclusions using multiplex assays to define sensitization for waitlisted candidates. We aimed to assess the impact of this change and review access to transplantation for highly sensitized patients under the current allocation rules. METHODS: Registry data was used to reconstruct changes in PRA/cPRA for all patients active on the waiting list between 2013-2018. A multilevel, mixed-effect negative binomial regression model was used to determine the association between sensitization and transplantation rate in the cPRA era. RESULTS: Following the introduction of cPRA there was an increase in the percentage of the waiting list classified as highly sensitized (PRA/cPRA ≥80%) from 7.2% to 27.8% and very highly sensitized (PRA/cPRA ≥99%) from 2.7% to 15.3%. Any degree of sensitization was associated with a decreased rate of transplantation with a marked reduction for those with cPRA 95-98% (adjusted incidence rate ratio (aIRR) 0.36, 95%CI 0.28-0.47, p<0.001) and cPRA ≥99% (aIRR 0.09, 95%CI 0.07-0.12, p<0.001). CONCLUSIONS: The proportion of the waiting list classified as highly sensitized increased substantially following the introduction of cPRA and despite current prioritization, very highly sensitized patients have markedly reduced access to deceased donor transplantation. |
Keywords: | Isoantibodies |
Rights: | Copyright © 2020 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited. |
DOI: | 10.1097/TP.0000000000003410 |
Grant ID: | http://purl.org/au-research/grants/nhmrc/GNT1092958 |
Published version: | http://dx.doi.org/10.1097/tp.0000000000003410 |
Appears in Collections: | Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.